This report studies Biosimilars in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Pfizer Sandoz International GmbH Teva Pharmaceuticals Industries Amgen Inc Biocon Dr. Reddy?s Laboratories F. Hoffmann-La Roche Celltrion Samsung Bioepis On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Peptides (Glucagon, Calcitonin) By Application, the market can be split into Oncology Blood Disorders By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents Global Biosimilars Market Professional Survey Report 2017 1 Industry Overview of Biosimilars 1.1 Definition and Specifications of Biosimilars 1.1.1 Definition of Biosimilars 1.1.2 Specifications of Biosimilars 1.2 Classification of Biosimilars 1.2.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) 1.2.2 Glycosylat
